{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:20:59Z","timestamp":1776763259357,"version":"3.51.2"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.tiv.2015.04.011","type":"journal-article","created":{"date-parts":[[2015,4,26]],"date-time":"2015-04-26T03:27:18Z","timestamp":1430018838000},"page":"1070-1078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Rat precision-cut intestinal slices to study P-gp activity and the potency of its inhibitors ex vivo"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4491-2226","authenticated-orcid":false,"given":"Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge A.M.","family":"de Graaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina H.","family":"de Jager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geny M.M.","family":"Groothuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2015.04.011_b0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1208\/s12248-008-9068-x","article-title":"P-gp inhibition potential in cell-based models: which \u201ccalculation\u201d method is the most accurate?","volume":"10","author":"Balimane","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.tiv.2015.04.011_b0010","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ejps.2008.12.005","article-title":"Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats","volume":"36","author":"Bansal","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2015.04.011_b0015","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/0140-6736(91)90273-R","article-title":"Intestinal involvement in drug-induced toxic epidermal necrolysis","volume":"337","author":"Chosidow","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.tiv.2015.04.011_b0020","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0090-9556(24)15193-8","article-title":"Increased post-thaw viability and phase I and II biotransformation activity in cryopreserved rat liver slices after improvement of a fast-freezing method","volume":"28","author":"de Graaf","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.011_b0025","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/nprot.2010.111","article-title":"Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies","volume":"5","author":"de Graaf","year":"2010","journal-title":"Nat. Protocols"},{"key":"10.1016\/j.tiv.2015.04.011_b0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.vascn.2004.07.007","article-title":"A new technique for preparing precision-cut slices from small intestine and colon for drug biotransformation studies","volume":"51","author":"de Kanter","year":"2005","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.tiv.2015.04.011_b0035","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1021\/mp500330y","article-title":"Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine","volume":"11","author":"Drozdzik","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tiv.2015.04.011_b0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.taap.2013.03.019","article-title":"ATP-dependent transport of statins by human and rat MRP2\/Mrp2","volume":"269","author":"Ellis","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2015.04.011_b9005","unstructured":"FDAwebsite, Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers. Available at: <http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/DrugInteractionsLabeling\/ucm093664.htm>."},{"key":"10.1016\/j.tiv.2015.04.011_b0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/clpt.2008.195","article-title":"Drug\u2013drug interactions mediated through P-glycoprotein: clinical relevance and in vitro\u2013in vivo correlation using digoxin as a probe drug","volume":"85","author":"Fenner","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2015.04.011_b0050","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2174\/138920007782109788","article-title":"The role of the intestine in drug metabolism and pharmacokinetics: an industry perspective","volume":"8","author":"Fisher","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.tiv.2015.04.011_b0055","doi-asserted-by":"crossref","first-page":"e33253","DOI":"10.1371\/journal.pone.0033253","article-title":"Characterization of Rhodamine-123 as a tracer dye for use in in vitro drug transport assays","volume":"7","author":"Forster","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tiv.2015.04.011_b0060","article-title":"Precision-cut intestinal slices as in vitro tool for studies on drug metabolism","author":"Groothuis","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.tiv.2015.04.011_b0065","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1021\/tx300248j","article-title":"Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury","volume":"25","author":"Hadi","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2015.04.011_b0070","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1073\/pnas.77.2.990","article-title":"Localization of mitochondria in living cells with Rhodamine 123","volume":"77","author":"Johnson","year":"1980","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tiv.2015.04.011_b0075","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/dmd.109.027490","article-title":"Culture period-dependent change of function and expression of ATP-Binding Cassette transporters in caco-2 Cells","volume":"37","author":"Kamiyama","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.011_b0080","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejps.2005.11.011","article-title":"Development, validation and utility of an in vitro technique for assessment of potential clinical drug\u2013drug interactions involving P-glycoprotein","volume":"27","author":"Keogh","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2015.04.011_b0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tiv.2010.09.011","article-title":"The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices","volume":"25","author":"Khan","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2015.04.011_b0090","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s11095-012-0942-y","article-title":"Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug\u2013drug interactions","volume":"30","author":"Kis","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2015.04.011_b0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1472-8206.2004.00291.x","article-title":"Functional interaction of intestinal CYP3A4 and P-glycoprotein","volume":"18","author":"Kivist\u00f6","year":"2004","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.tiv.2015.04.011_b0100","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/pr.113.007518","article-title":"Transporters and drug\u2013drug interactions: important determinants of drug disposition and effects","volume":"65","author":"K\u00f6nig","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tiv.2015.04.011_b0105","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/dmd.30.6.626","article-title":"Intestinal secretion is a major route for parent ivermectin elimination in the rat","volume":"30","author":"Laffont","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.011_b0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2010.10.017","article-title":"Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion","volume":"403","author":"Li","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tiv.2015.04.011_b0115","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/dmd.108.020859","article-title":"Closing the Gaps: a full scan of the intestinal expression of P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats","volume":"36","author":"MacLean","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.011_b0120","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1124\/dmd.105.009035","article-title":"Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine","volume":"34","author":"Martignoni","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.011_b0125","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/jps.23069","article-title":"Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK\u2013MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2","volume":"101","author":"Mease","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2015.04.011_b0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00498254.2012.729870","article-title":"Evaluation of the intestinal toxicity and transport of xenobiotics utilizing precision-cut slices","volume":"43","author":"Niu","year":"2013","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tiv.2015.04.011_b0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ctrv.2008.09.004","article-title":"The biological and clinical role of drug transporters at the intestinal barrier","volume":"35","author":"Oostendorp","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.tiv.2015.04.011_b0140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejpb.2011.04.004","article-title":"Rat intestinal precision-cut slices as an in vitro model to study xenobiotic interaction with transporters","volume":"79","author":"Possidente","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.tiv.2015.04.011_b0145","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/dmd.105.008615","article-title":"In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates","volume":"34","author":"Rautio","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.011_b0150","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejps.2012.02.025","article-title":"Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs","volume":"46","author":"Rozehnal","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2015.04.011_b0155","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.bbadis.2011.07.015","article-title":"Interaction of Mrp2 with radixin causes reversible canalicular Mrp2 localization induced by intracellular redox status","volume":"1812","author":"Sekine","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Mol. Basis Disease"},{"key":"10.1016\/j.tiv.2015.04.011_b0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/dmd.110.035774","article-title":"Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats","volume":"39","author":"Sugimoto","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.011_b0165","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1020483911355","article-title":"Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs","volume":"19","author":"Sun","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2015.04.011_b0170","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/jps.20787","article-title":"Species differences of inhibitory effects on P-glycoprotein-mediated drug transport","volume":"96","author":"Suzuyama","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2015.04.011_b0175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00685714","article-title":"Metabolism and elimination of Rhodamine 123 in the rat","volume":"27","author":"Sweatman","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tiv.2015.04.011_b0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pharmthera.2005.06.005","article-title":"Expression and function of efflux drug transporters in the intestine","volume":"109","author":"Takano","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2015.04.011_b0185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"The International Transporter Consortium","year":"2010","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.tiv.2015.04.011_b0190","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1124\/dmd.105.005686","article-title":"Characterization of rat small intestinal and colon precision-cut slices as an in vitro system for drug metabolism and induction studies","volume":"33","author":"van de Kerkhof","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.011_b0195","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1124\/dmd.106.011148","article-title":"Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with Ussing chamber preparations","volume":"34","author":"van de Kerkhof","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.011_b0200","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1124\/dmd.106.014563","article-title":"Induction of phase I and II drug metabolism in rat small intestine and colon in vitro","volume":"35","author":"van de Kerkhof","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.011_b0205","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1124\/dmd.107.018820","article-title":"Induction of metabolism and transport in human intestine: validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro","volume":"36","author":"van de Kerkhof","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.011_b0210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/138920010794328850","article-title":"Targeting intestinal transporters for optimizing oral drug absorption","volume":"11","author":"Varma","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.tiv.2015.04.011_b0215","first-page":"3944","article-title":"P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies","volume":"59","author":"Wandel","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.tiv.2015.04.011_b0220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/dmd.105.007377","article-title":"Evaluation of inhibitory potencies for compounds inhibiting P-glycoprotein but without maximum effects: f2 values","volume":"34","author":"Weiss","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2015.04.011_b0225","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1211\/jpp.59.9.0011","article-title":"Role of intestinal efflux transporters in the intestinal absorption of methotrexate in rats","volume":"59","author":"Yokooji","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.tiv.2015.04.011_b0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-3565(24)38117-0","article-title":"Transport of Rhodamine 123, a P-glycoprotein substrate, across rat intestine and caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds","volume":"289","author":"Yumoto","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2015.04.011_b0235","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/00498250802017715","article-title":"A regulatory viewpoint on transporter-based drug interactions","volume":"38","author":"Zhang","year":"2008","journal-title":"Xenobiotica"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723331500082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723331500082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:04:41Z","timestamp":1748358281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088723331500082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S088723331500082X"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2015.04.011","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rat precision-cut intestinal slices to study P-gp activity and the potency of its inhibitors ex vivo","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2015.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}